Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §
Authors
Keywords
-
Journal
SENSORS
Volume 21, Issue 18, Pages 6131
Publisher
MDPI AG
Online
2021-09-14
DOI
10.3390/s21186131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
- (2021) Guido Freckmann et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
- (2021) Margaretha M Visser et al. LANCET
- The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond
- (2021) Pratik Choudhary et al. Diabetes Therapy
- Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials
- (2020) Maria Ida Maiorino et al. DIABETES CARE
- Hypoglycemia Unawareness and Autonomic Dysfunction in Diabetes – Lessons Learned and Roles of Diabetes Technologies
- (2020) Yu Kuei Lin et al. Journal of Diabetes Investigation
- Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials
- (2020) I. Dicembrini et al. ACTA DIABETOLOGICA
- 68-OR: Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study
- (2020) RONAN ROUSSEL et al. DIABETES
- Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes
- (2020) Ajenthen G. Ranjan et al. DIABETES CARE
- Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial
- (2020) Aneta Hásková et al. DIABETES CARE
- Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices
- (2020) Yannis Préau et al. Diabetes Technology & Therapeutics
- Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
- (2020) Jee Hee Yoo et al. Diabetes & Metabolism Journal
- A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes
- (2019) P. Choudhary et al. DIABETIC MEDICINE
- Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management
- (2019) Zainab Mian et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Double diabetes: A distinct high‐risk group?
- (2019) Noppadol Kietsiriroje et al. DIABETES OBESITY & METABOLISM
- Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes
- (2019) Halis Kaan Akturk et al. DIABETES OBESITY & METABOLISM
- Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution
- (2019) David Rodbard Diabetes Technology & Therapeutics
- Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
- (2019) Jelena Kravarusic et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement
- (2018) S. Borot et al. DIABETES & METABOLISM
- Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice
- (2018) Ramzi A Ajjan et al. Diabetes & Vascular Disease Research
- Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study
- (2018) Sara Charleer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
- (2018) Monika Reddy et al. Diabetes Technology & Therapeutics
- Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring
- (2018) Steven V. Edelman et al. DIABETES CARE
- The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
- (2018) Robert A. Vigersky et al. Diabetes Technology & Therapeutics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started